Giant Biogene Holding Co., Ltd.

SEHK:2367 Stock Report

Market Cap: HK$50.3b

Giant Biogene Holding Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jianya Yan

Chief executive officer

CN¥11.9m

Total compensation

CEO salary percentage5.1%
CEO tenure2.6yrs
CEO ownership0.09%
Management average tenureno data
Board average tenure2.1yrs

Recent management updates

Recent updates

Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%

Aug 21
Revenue Beat: Giant Biogene Holding Co., Ltd. Beat Analyst Estimates By 12%

Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?

Aug 09
Does Giant Biogene Holding (HKG:2367) Deserve A Spot On Your Watchlist?

Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear

Jul 01
Giant Biogene Holding Co., Ltd.'s (HKG:2367) Popularity With Investors Is Clear

Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?

Apr 17
Is Giant Biogene Holding Co., Ltd. (HKG:2367) Trading At A 32% Discount?

Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings

Mar 28
Investors Interested In Giant Biogene Holding Co., Ltd.'s (HKG:2367) Earnings

Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Mar 27
Giant Biogene Holding Co., Ltd. Just Recorded A 6.9% EPS Beat: Here's What Analysts Are Forecasting Next

Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?

Dec 24
Do Giant Biogene Holding's (HKG:2367) Earnings Warrant Your Attention?

A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)

Oct 30
A Look At The Intrinsic Value Of Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion

Mar 28
Giant Biogene Holding Co., Ltd.'s (HKG:2367) Share Price Matching Investor Opinion

CEO Compensation Analysis

How has Jianya Yan's remuneration changed compared to Giant Biogene Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥2b

Mar 31 2024n/an/a

CN¥2b

Dec 31 2023CN¥12mCN¥606k

CN¥1b

Sep 30 2023n/an/a

CN¥1b

Jun 30 2023n/an/a

CN¥1b

Mar 31 2023n/an/a

CN¥874m

Dec 31 2022CN¥10mCN¥600k

CN¥696m

Dec 31 2021CN¥10mCN¥600k

CN¥809m

Compensation vs Market: Jianya's total compensation ($USD1.64M) is above average for companies of similar size in the Hong Kong market ($USD735.87K).

Compensation vs Earnings: Jianya's compensation has been consistent with company performance over the past year.


CEO

Jianya Yan (58 yo)

2.6yrs

Tenure

CN¥11,885,000

Compensation

Mr. Jianya Yan is Co-Founder of Giant Biogene Holding Co., Ltd., serves as its Chief Executive Officer, Executive Director & Chairman of the Board since April 21, 2022 and served as its Director since Nove...


Board Members

NamePositionTenureCompensationOwnership
Jianya Yan
CEO & Executive Chairman of the Board3yrsCN¥11.89m0.089%
HK$ 44.9m
Huijuan Zhang
CFO & Executive Director1.1yrsCN¥241.00kno data
Juan Ye
Senior VP & Executive Director3yrsCN¥1.82mno data
Juan Fang
Senior VP & Executive Director3yrsCN¥2.11mno data
Yubo Yan
Chief Product Officer1.1yrsCN¥140.00kno data
Sze Wing Wong
Independent Non-Executive Director2.1yrsCN¥180.00kno data
Wenhua Shan
Independent Non-Executive Director2.1yrsCN¥108.00kno data
Jin Huang
Independent Non-Executive Director2.1yrsCN¥108.00kno data

2.1yrs

Average Tenure

51yo

Average Age

Experienced Board: 2367's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.